A. Bashford
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
.
Lancet Oncology.
2017
Contact
full name
A.
Bashford
Quick Info
Collaboration
Co-author network
Map of science
Picked up by
33
news outlets
Referenced in
1
policy sources
Posted by
30
X users
Referenced in
2
patents
On
2
Facebook pages
On
1
videos
Referenced in
3
clinical guideline sources
526
readers on Mendeley
See more details